229 related articles for article (PubMed ID: 24884630)
21. Long noncoding RNA B3GALT5-AS1 suppresses colon cancer liver metastasis via repressing microRNA-203.
Wang L; Wei Z; Wu K; Dai W; Zhang C; Peng J; He Y
Aging (Albany NY); 2018 Dec; 10(12):3662-3682. PubMed ID: 30530918
[TBL] [Abstract][Full Text] [Related]
22. Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor.
Nagy N; Bronckart Y; Camby I; Legendre H; Lahm H; Kaltner H; Hadari Y; Van Ham P; Yeaton P; Pector JC; Zick Y; Salmon I; Danguy A; Kiss R; Gabius HJ
Gut; 2002 Mar; 50(3):392-401. PubMed ID: 11839721
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.
Luo BH; Xiong F; Wang JP; Li JH; Zhong M; Liu QL; Luo GQ; Yang XJ; Xiao N; Xie B; Xiao H; Liu RJ; Dong CS; Wang KS; Wen JF
PLoS One; 2014; 9(6):e99922. PubMed ID: 24945379
[TBL] [Abstract][Full Text] [Related]
24. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
[TBL] [Abstract][Full Text] [Related]
25. Knockdown or inhibition of aldo-keto reductase 1B10 inhibits pancreatic carcinoma growth via modulating Kras-E-cadherin pathway.
Zhang W; Li H; Yang Y; Liao J; Yang GY
Cancer Lett; 2014 Dec; 355(2):273-80. PubMed ID: 25304374
[TBL] [Abstract][Full Text] [Related]
26. Aldo-keto reductase 1B10 protects human colon cells from DNA damage induced by electrophilic carbonyl compounds.
Zu X; Yan R; Pan J; Zhong L; Cao Y; Ma J; Cai C; Huang D; Liu J; Chung FL; Liao DF; Cao D
Mol Carcinog; 2017 Jan; 56(1):118-129. PubMed ID: 26969882
[TBL] [Abstract][Full Text] [Related]
27. Intra-tumoral heterogeneity in metastatic potential and survival signaling between iso-clonal HCT116 and HCT116b human colon carcinoma cell lines.
Chowdhury S; Ongchin M; Sharratt E; Dominguez I; Wang J; Brattain MG; Rajput A
PLoS One; 2013; 8(4):e60299. PubMed ID: 23560089
[TBL] [Abstract][Full Text] [Related]
28. Tensin3 is a negative regulator of cell migration and all four Tensin family members are downregulated in human kidney cancer.
Martuszewska D; Ljungberg B; Johansson M; Landberg G; Oslakovic C; Dahlbäck B; Hafizi S
PLoS One; 2009; 4(2):e4350. PubMed ID: 19194507
[TBL] [Abstract][Full Text] [Related]
29. The acid-sensing ion channel, ASIC2, promotes invasion and metastasis of colorectal cancer under acidosis by activating the calcineurin/NFAT1 axis.
Zhou ZH; Song JW; Li W; Liu X; Cao L; Wan LM; Tan YX; Ji SP; Liang YM; Gong F
J Exp Clin Cancer Res; 2017 Sep; 36(1):130. PubMed ID: 28927426
[TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor β potentiates the antiproliferative effect of raloxifene and affects the cell migration and invasion in HCT-116 colon cancer cells.
Tu Z; Ma Y; Tian J; Li H; Akers W; Achilefu S; Gu Y
J Cancer Res Clin Oncol; 2012 Jul; 138(7):1091-103. PubMed ID: 22398780
[TBL] [Abstract][Full Text] [Related]
31. AKR1B10, a transcriptional target of p53, is downregulated in colorectal cancers associated with poor prognosis.
Ohashi T; Idogawa M; Sasaki Y; Suzuki H; Tokino T
Mol Cancer Res; 2013 Dec; 11(12):1554-63. PubMed ID: 24140838
[TBL] [Abstract][Full Text] [Related]
32. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
[TBL] [Abstract][Full Text] [Related]
33. Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29.
Ebert B; Kisiela M; Wsól V; Maser E
Chem Biol Interact; 2011 May; 191(1-3):239-49. PubMed ID: 21215737
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of aldose reductase prevents colon cancer metastasis.
Tammali R; Reddy AB; Saxena A; Rychahou PG; Evers BM; Qiu S; Awasthi S; Ramana KV; Srivastava SK
Carcinogenesis; 2011 Aug; 32(8):1259-67. PubMed ID: 21642355
[TBL] [Abstract][Full Text] [Related]
35. Pristimerin inhibits proliferation, migration and invasion, and induces apoptosis in HCT-116 colorectal cancer cells.
Yousef BA; Hassan HM; Guerram M; Hamdi AM; Wang B; Zhang LY; Jiang ZZ
Biomed Pharmacother; 2016 Apr; 79():112-9. PubMed ID: 27044819
[TBL] [Abstract][Full Text] [Related]
36. C-terminal Tensin-like (CTEN) is an oncogene which alters cell motility possibly through repression of E-cadherin in colorectal cancer.
Albasri A; Seth R; Jackson D; Benhasouna A; Crook S; Nateri AS; Chapman R; Ilyas M
J Pathol; 2009 May; 218(1):57-65. PubMed ID: 19214987
[TBL] [Abstract][Full Text] [Related]
37. Pathophysiological roles of autophagy and aldo-keto reductases in development of doxorubicin resistance in gastrointestinal cancer cells.
Matsunaga T; Kawabata S; Yanagihara Y; Kezuka C; Kato M; Morikawa Y; Endo S; Chen H; Iguchi K; Ikari A
Chem Biol Interact; 2019 Dec; 314():108839. PubMed ID: 31563593
[TBL] [Abstract][Full Text] [Related]
38. [Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis].
Wang GH; Lu MH; Wang JC; Wang F; Ding WF; Wang YG; Ju SQ; Wang HM
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):249-55. PubMed ID: 23985251
[TBL] [Abstract][Full Text] [Related]
39. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
[TBL] [Abstract][Full Text] [Related]
40. The roles of miR-200c in colon cancer and associated molecular mechanisms.
Chen J; Wang W; Zhang Y; Hu T; Chen Y
Tumour Biol; 2014 Jul; 35(7):6475-83. PubMed ID: 24682933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
